换一批SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection.
第一作者：
Sandile,Cele
第一单位：
Africa Health Research Institute, Durban, South Africa.;School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
作者：
Sandile,Cele [1]
;
Laurelle,Jackson [2]
;
David S,Khoury [3]
;
Khadija,Khan [1]
;
Thandeka,Moyo-Gwete [4]
;
Houriiyah,Tegally [5]
;
James Emmanuel,San [6]
;
Deborah,Cromer [3]
;
Cathrine,Scheepers [4]
;
Daniel,Amoako [7]
;
Farina,Karim [1]
;
Mallory,Bernstein [2]
;
Gila,Lustig [8]
;
Derseree,Archary [9]
;
Muneerah,Smith [10]
;
Yashica,Ganga [2]
;
Zesuliwe,Jule [2]
;
Kajal,Reedoy [2]
;
Shi-Hsia,Hwa [11]
;
Jennifer,Giandhari [6]
;
Jonathan M,Blackburn [12]
;
Bernadett I,Gosnell [13]
;
Salim S,Abdool Karim [14]
;
Willem,Hanekom [11]
;
NGS-SA [4]
;
COMMIT-KZN Team [4]
;
Anne,von Gottberg [15]
;
Jinal,Bhiman [13]
;
Richard J,Lessells [3]
;
Mahomed-Yunus S,Moosa [16]
;
Miles P,Davenport [17]
;
Tulio,de Oliveira [18]
;
Penny L,Moore ;
Alex,Sigal
作者单位：
Africa Health Research Institute, Durban, South Africa.;School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
[1]
Africa Health Research Institute, Durban, South Africa.
[2]
Kirby Institute, University of New South Wales, Sydney, Australia.
[3]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.;MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
[4]
KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.;Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
[5]
KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
[6]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
[7]
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
[8]
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.;Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa.
[9]
Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
[10]
Africa Health Research Institute, Durban, South Africa.;Division of Infection and Immunity, University College London, London, UK.
[11]
Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.;Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
[12]
Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
[13]
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.;Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
[14]
KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.;Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.;Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
[15]
KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.;Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.;Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.;Department of Global Health, University of Washington, Seattle, USA.
[16]
National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.;MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.;Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.;Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
[17]
Africa Health Research Institute, Durban, South Africa.;School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.;Max Planck Institute for Infection Biology, Berlin, Germany.
[18]
DOI
10.1101/2021.12.08.21267417
PMID
34909788
发布时间
2024-12-07
- 浏览1
medRxiv
medRxiv
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
